FDA panels probe efficacy of barrier contraceptives.
Turnbull
W
W
D000569:Americas; D003257:Consumer Product Safety; D003267:Contraception; D003270:Contraceptive Agents; D003274:Contraceptive Devices, Female; D019049:Developed Countries; D004194:Disease; D005193:Family Planning Services; D006077:Government Agencies; D007239:Infections; D019359:Knowledge; D017137:Nonoxynol; D009656:North America; D009938:Organizations; D012749:Sexually Transmitted Diseases; D013089:Spermatocidal Agents; D014481:United States; D014486:United States Food and Drug Administration; D014492:United States Public Health Service
D003270:Contraceptive Agents; D013089:Spermatocidal Agents; D017137:Nonoxynol
Americas; Barrier Methods; Cervical Cap; Contraception; Contraceptive Agents; Contraceptive Methods; Developed Countries; Diseases; Family Planning; Government Agencies; Infections; Knowledge; Nonoxynol-9; North America; Northern America; Organizations; Product Approval; Reproductive Tract Infections; Sexually Transmitted Diseases--prevention and control; Spermicidal Contraceptive Agents; United States; Usfda; Usphs; Vaginal Barrier Methods; Vaginal Spermicides